Intervention Protocol

Fluoxetine for multiple sclerosis

  1. Seyed Mohammad Reza Hosseini*,
  2. Masih Tajdini,
  3. Amirhossein Modabbernia,
  4. Shahin Akhondzadeh

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 16 MAY 2012

Assessed as up-to-date: 30 MAR 2012

DOI: 10.1002/14651858.CD009866

How to Cite

Hosseini SMR, Tajdini M, Modabbernia A, Akhondzadeh S. Fluoxetine for multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD009866. DOI: 10.1002/14651858.CD009866.

Author Information

  1. Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Department of Psychiatry, Tehran, Iran

*Seyed Mohammad Reza Hosseini, Department of Psychiatry, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Street, Tehran, 13337, Iran.

Publication History

  1. Publication Status: New
  2. Published Online: 16 MAY 2012


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.